Hisao Nakai - Concepedia

Author

Hisao Nakai

Ono Pharmaceutical (Japan)ORCID

Also Known As

H NAKAI, H Nakai, H. NAKAI, H. Nakai, HISAO NAKAI, Hisao NAKAI, Hisao Nakai, Nakai, H., Nakai, Hisao, Takayuki Maruyama

211

Publications

2.7K

Citations

H-Index

Concepts

All Affiliations

Ono Pharmaceutical (Japan)Ono Pharmaceutical (United States)Kanazawa University Kanazawa Medical University

About

Hisao Nakai is an author at Ono Pharmaceutical (Japan) specializing in medicine, drug discovery, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	66	1.8K
2	Natural Sciences	22	40	1.3K
3	Engineering	6	6	122
4	Nursing	1	1	14
5	Public Health	1	1	16

Hisao Nakai

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
Clinical outcome of endoscopic aspiration mucosectomy for early stage gastric cancer Satoshi Tanabe, Wasaburo Koizumi, Hiroyuki Mitomi, Gastrointestinal Endoscopy Endoscopic Aspiration MucosectomyMedicineGastroenterologySurgeryUpper Gastrointestinal Surgery	2002	141
Diisobutylaluminum 2,6-di-tert-butyl-4-methylphenoxide. Novel stereoselective reducing agent for prostaglandin synthesis Sadahiko Iguchi, Hisao Nakai, Masaki Hayashi, The Journal of Organic Chemistry Pharmaceutical ScienceBioorganic ChemistryProstaglandin SynthesisAltmetric Attention ScoreOrganic Chemistry	1979	102
Discovery of a new class of potent, selective, and orally active prostaglandin D2 receptor antagonists Kazuhiko Torisu, Kaoru Kobayashi, Maki Iwahashi, Bioorganic & Medicinal Chemistry BiochemistryFunctional SelectivityMedicineG Protein-coupled ReceptorReceptor (Biochemistry)	2004	101
Asymmetric simmons-smith reactions using homochiral protecting groups Atsunori Mori, Isao Arai, Hisashi Yamamoto, Tetrahedron PhysicsNatural SciencesReactivity (Chemistry)Computational ChemistryChemistry	1986	94
New potent antagonists of leukotrienes C4 and D4. 1. Synthesis and structure-activity relationships Hisao Nakai, Mitoshi Konno, Shunji Kosuge, Journal of Medicinal Chemistry	1988	88
Novel 5-HT3 antagonists. Isoquinolinones and 3-aryl-2-pyridones Toshiaki Matsui, Tsuneyuki Sugiura, Hisao Nakai, Journal of Medicinal Chemistry Molecular PharmacologyMedicinal ChemistryPharmacological StudyBiochemistryMedicine	1992	71
Development of Orally Active Nonpeptidic Inhibitors of Human Neutrophil Elastase Kazuyuki Ohmoto, Tetsuya Yamamoto, Motohiro Okuma, Journal of Medicinal Chemistry Pharmaceutical ScienceBioorganic ChemistryImmunologyPharmacotherapyPharmaceutical Chemistry	2001	64
Diisobutylaluminum 2,6-Di-<i>t</i>-butyl-4-methylphenoxide. Novel Stereoselective Reducing Agent for Prostaglandin Synthesis Sadahiko Iguchi, Hisao Nakai, Masaki Hayashi, Bulletin of the Chemical Society of Japan Medicinal ChemistryPge2 Methyl EsterDerivativesProstaglandin SynthesisNatural Sciences	1981	61
Design and Synthesis of New Orally Active Nonpeptidic Inhibitors of Human Neutrophil Elastase Kazuyuki Ohmoto, Tetsuya Yamamoto, Toshihide Horiuchi, Journal of Medicinal Chemistry Molecular PharmacologyMedicinal ChemistryAntimicrobial Drug DiscoveryHuman Neutrophil ElastasePharmaceutical Science	2000	56
An efficient and stereoselective synthesis of platelet-activating factors and the enantiomers from D- and L- tartaric acids Kagari Fujita, Hisao Nakai, Susumu Kobayashi, Tetrahedron Letters Medicinal ChemistryNatural Product SynthesisPlatelet-activating FactorsBioorganic ChemistryBiochemistry	1982	55

Page 1